These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17425417)

  • 1. Serologic prevalence of coxsackievirus group B in Greece.
    Mavrouli MD; Spanakis N; Levidiotou S; Politi C; Alexiou S; Tseliou P; Hatzitaki M; Foundouli K; Tsakris A; Legakis NJ; Routsias JG
    Viral Immunol; 2007; 20(1):11-8. PubMed ID: 17425417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of IgM antibodies against coxsackie B viruses by a western blot technique.
    del Rosario Zuñiga M; Reichardt J; Braun W; Weber B; Doerr HW
    Acta Virol; 1993 Feb; 37(1):1-10. PubMed ID: 8105643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of levels of antibody against coxsackievirus B in different adults in Changsha area].
    Xie M; Tan H; Pu P
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):128-30. PubMed ID: 11938768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus.
    D'Alessio DJ
    Am J Epidemiol; 1992 Jun; 135(12):1331-8. PubMed ID: 1324601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptides for efficient discrimination of anti-enterovirus antibodies at the serotype level.
    Routsias JG; Mavrouli MD; Antonaki G; Spanakis N; Tsakris A
    Peptides; 2014 Aug; 58():52-9. PubMed ID: 24929043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans.
    Lim BK; Ju ES; Lao DH; Yun SH; Lee YJ; Kim DK; Jeon ES
    Microbiol Immunol; 2013 Apr; 57(4):281-7. PubMed ID: 23586632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiological evidence of widespread enteroviral infection in Anambra State, Nigeria.
    Iroegbu CU
    Arch Roum Pathol Exp Microbiol; 1990; 49(1):63-9. PubMed ID: 1966236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.
    Morgan-Capner P; McSorley C
    J Hyg (Lond); 1983 Jun; 90(3):333-49. PubMed ID: 6306097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.
    King ML; Shaikh A; Bidwell D; Voller A; Banatvala JE
    Lancet; 1983 Jun; 1(8339):1397-9. PubMed ID: 6134178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse radioimmunoassays of IgM and IgG antibodies to Coxsackie B viruses in patients with acute myopericarditis.
    Frisk G; Torfason EG; Diderholm H
    J Med Virol; 1984; 14(3):191-200. PubMed ID: 6094719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes.
    Hober D; Sane F; Jaïdane H; Riedweg K; Goffard A; Desailloud R
    Clin Exp Immunol; 2012 Apr; 168(1):47-51. PubMed ID: 22385236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackievirus B3 infection induces anti-flavoprotein antibodies in mice.
    Cicek G; Vuorinen T; Stähle I; Stepanek P; Freudenberg N; Brandsch R
    Clin Exp Immunol; 2000 Dec; 122(3):404-9. PubMed ID: 11122247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Coxsackie B virus IgM antibody in myocarditis patients by Mac ELISA.
    Zhu H; Zhang LB
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):370-2. PubMed ID: 11471030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of IgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique.
    Dörries R; ter Meulen V
    J Gen Virol; 1983 Jan; 64 (Pt 1)():159-67. PubMed ID: 6185632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
    Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
    Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outbreak of Coxsackievirus B5 meningoencephalitis in Cuba, 1995].
    Bello M; Más Lago P; Palomera R; González Z
    Rev Cubana Med Trop; 1997; 49(1):69-70. PubMed ID: 9685965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin M capture immunoassay in investigation of coxsackievirus B5 and B6 outbreaks in South Australia.
    Goldwater PN
    J Clin Microbiol; 1995 Jun; 33(6):1628-31. PubMed ID: 7650200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice.
    Davydova B; Härkönen T; Kaialainen S; Hovi T; Vaarala O; Roivainen M
    J Med Virol; 2003 Apr; 69(4):510-20. PubMed ID: 12601759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxsackievirus B3 sequences in the myocardium of fatal cases in a cluster of acute myocarditis in Greece.
    Spanakis N; Manolis EN; Tsakris A; Tsiodras S; Panagiotopoulos T; Saroglou G; Legakis NJ
    J Clin Pathol; 2005 Apr; 58(4):357-60. PubMed ID: 15790697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marker of coxsackievirus-B4 infection in saliva of patients with type 1 diabetes.
    Badia-Boungou F; Sane F; Alidjinou EK; Ternois M; Opoko PA; Haddad J; Stukens C; Lefevre C; Gueorguieva I; Hamze M; Ismail M; Weill J; Monabéka HG; Bouenizabila E; Moukassa D; Abena AA; Hober D
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.